Literature DB >> 14559903

Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library.

Kazuko Shiraishi1, Shunsuke Kato, Shuang-Yin Han, Wen Liu, Kazunori Otsuka, Masato Sakayori, Takanori Ishida, Motohiro Takeda, Ryunosuke Kanamaru, Noriaki Ohuchi, Chikashi Ishioka.   

Abstract

Temperature-sensitive (ts) mutations have been used as a genetic and molecular tool to study the functions of many gene products. Each ts mutant protein may contain a temperature-dependent intramolecular mechanism such as ts conformational change. To identify key ts structural elements controlling the protein function, we screened ts p53 mutants from a comprehensive mutation library consisting of 2,314 p53 missense mutations for their sequence-specific transactivity through p53-binding sequences in Saccharomyces cerevisiae. We isolated 142 ts p53 mutants, including 131 unreported ts mutants. These mutants clustered in beta-strands in the DNA-binding domain, particularly in one of the two beta-sheets of the protein, and 15 residues (Thr155, Arg158, Met160, Ala161, Val172, His214, Ser215, Pro223, Thr231, Thr253, Ile254, Thr256, Ser269, Glu271, and Glu285) were ts hot spots. Among the 142 mutants, 54 were examined further in human osteosarcoma Saos-2 cells, and it was confirmed that 89% of the mutants were also ts in mammalian cells. The ts mutants represented distinct ts transactivities for the p53 binding sequences and a distinct epitope expression pattern for conformation-specific anti-p53 antibodies. These results indicated that the intramolecular beta-sheet in the core DNA-binding domain of p53 was a key structural element controlling the protein function and provided a clue for finding a molecular mechanism that enables the rescue of the mutant p53 function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559903     DOI: 10.1074/jbc.M310815200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.

Authors:  Guang-Xia Chen; Li-Hong Zheng; Shi-Yu Liu; Xiao-Hua He
Journal:  World J Gastroenterol       Date:  2011-10-14       Impact factor: 5.742

2.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

4.  Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.

Authors:  Jennifer J Jordan; Alberto Inga; Kathleen Conway; Sharon Edmiston; Lisa A Carey; Lin Wu; Michael A Resnick
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

5.  tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors.

Authors:  Stéphane Berghmans; Ryan D Murphey; Erno Wienholds; Donna Neuberg; Jeffery L Kutok; Christopher D M Fletcher; John P Morris; Ting Xi Liu; Stefan Schulte-Merker; John P Kanki; Ronald Plasterk; Leonard I Zon; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

6.  Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.

Authors:  Elena N Voropaeva; Tatyana I Pospelova; Mikhail I Voevoda; Vladimir N Maksimov; Yuriy L Orlov; Olga B Seregina
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

7.  High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Authors:  Jana Smardova; Kvetoslava Liskova; Barbora Ravcukova; Lenka Kubiczkova; Sabina Sevcikova; Jaroslav Michalek; Miluse Svitakova; Vaclav Vybihal; Leos Kren; Jan Smarda
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

8.  A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Authors:  Jessica A Monteith; Hestia Mellert; Morgan A Sammons; Laudita A Kuswanto; Stephen M Sykes; Lois Resnick-Silverman; James J Manfredi; Shelley L Berger; Steven B McMahon
Journal:  Mol Oncol       Date:  2016-06-07       Impact factor: 6.603

9.  The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30.

Authors:  Ophira M Ginsburg; Mohammad R Akbari; Zeba Aziz; Robert Young; Henry Lynch; Parviz Ghadirian; Andre Robidoux; Julian Londono; Gonzalo Vasquez; Magda Gomes; Mauricio Magalhaes Costa; Constantine Dimitrakakis; Gustavo Gutierrez; Robert Pilarski; Robert Royer; Steven A Narod
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

10.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.